Bioregulator Hepatic / Digestive

Research Benefits

• Hepatocyte Function Support: Studied for its role in maintaining liver cell protein synthesis and detoxification enzyme activity in aging models
• Digestive Enzyme Regulation: Research explores its influence on pancreatic and intestinal enzyme expression for optimal nutrient processing
• Liver Regeneration Research: Investigated for potential enhancement of hepatocyte proliferation and tissue repair following toxin-induced damage
• Bile Acid Metabolism: Explored for modulation of bile salt synthesis and transport proteins, supporting efficient lipid digestion pathways
• Hepatoprotective Properties: Preclinical studies suggest protective effects against oxidative damage and fibrotic changes in liver tissue

Mechanism of Action

The hepatic/digestive bioregulator belongs to the Khavinson class of organ-specific short peptides. These peptides interact with DNA regulatory regions in hepatocytes and digestive gland cells, modulating the expression of proteins essential for metabolic and detoxification functions.

Key Pathways

• Hepatocyte Gene Activation: Targets promoter regions of cytochrome P450 enzymes and phase II conjugation enzymes, potentially restoring age-declined detoxification capacity
• Protein Synthesis Restoration: Epigenetic modulation of chromatin structure in liver cells, enabling transcription of albumin, transferrin, and other functional hepatic proteins
• Anti-Fibrotic Signaling: Research suggests downregulation of TGF-beta and collagen deposition pathways in stellate cells
• Antioxidant Gene Expression: Upregulation of glutathione S-transferase and other hepatic antioxidant defense enzymes

Research Protocol

For research purposes only. Not for human consumption.

• Typical Research Dose: 10-20 mg per administration in preclinical protocols
• Administration Route: Subcutaneous injection
• Research Cycle: 10-20 day cycles as reported in bioregulator literature
• Frequency: Once daily in most published study designs

Reconstitution

• Reconstitute with bacteriostatic water
• Gently swirl to dissolve; avoid vigorous shaking
• Use within 30 days of reconstitution when refrigerated at 2-8 °C

Safety & Storage

• Lyophilized Storage: -20 °C for long-term; 2-8 °C for up to 12 months
• Reconstituted: 2-8 °C; use within 30 days
• Protect from light and avoid freeze-thaw cycles

Research Considerations

• Reported as well-tolerated across Khavinson's preclinical and clinical research publications
• Exercise caution when studying alongside hepatotoxic compounds or CYP450 substrates
• Not intended for combination with immunosuppressive protocols without appropriate review
• For research use only

Frequently Asked Questions

• What distinguishes a hepatic bioregulator from liver-support supplements?

  Unlike nutritional supplements that provide substrates for liver function, bioregulatory peptides are designed to interact at the gene expression level, potentially restoring the liver's own capacity for protein synthesis and enzymatic activity.

• Is this derived from animal tissue?

  BeaCapra's bioregulators are synthetically manufactured peptides inspired by the sequences identified in Khavinson's tissue-extraction research. They are produced to ≥99% purity via solid-phase synthesis.

• Can this be combined with other bioregulators?

  Published research frequently employs multi-organ bioregulator panels. The hepatic bioregulator is commonly studied in combination with cardiovascular and immune bioregulators for systemic protocols.

• How is purity verified?

  Each batch undergoes HPLC and mass spectrometry analysis. Certificates of Analysis are available for every product.